Dr María Adelaida Gómez is a Colombian biomedical scientist specialising in neglected infectious diseases, with a particular focus on human leishmaniasis. Her research delves into the complex interactions between the Leishmania parasite and the human immune system, aiming to understand why some individuals develop severe disease while others recover. By exploring mechanisms of drug resistance, immune response, and disease progression, she seeks to improve treatments for those affected by this often-overlooked disease.
Leishmaniasis is a significant public health concern in Colombia, with over 11 million people at risk and thousands of cases reported annually, predominantly in rural and underserved areas. Dr Gómez's work is deeply rooted in these communities. She has actively engaged with rural and indigenous populations, such as the Wiwa communities in the Sierra Nevada de Santa Marta, conducting training sessions on disease recognition and sample collection, and collaborating on initiatives to enhance local diagnostic capabilities (cideim.org.co).
At CIDEIM in Cali, Adelaida leads the Molecular Biology and Biochemistry Lab, and her research has garnered support from major international funders, including Wellcome and the US National Institutes of Health. As Co-Director of the VALIDATE Network, she fosters global collaboration to accelerate vaccine development for leishmaniasis and other neglected diseases.